📰 Co Diagnostics News
Co Diagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Co Diagnostics. Real-time updates on events, politics, business and more.
July 16, 2024
Some resolution to the types of. Senseless acts of violence how californias top cop joined forces with Union City Police to put him behind bars. Thank you for joining us tonight at 5 oclock everybody im grant lotus and im Vicki Liviakis tonight, californias attorney general joins Union City Police. And announcing the arrest of 2 suspects in connection with the murder of 2 teenagers that double murder of course shocked the Community Family and friends of the 2 boys just 1114 years old kron fours ...
April 25, 2024
/PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular...
February 29, 2024
Dublin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The
February 27, 2024
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The
February 27, 2024
/PRNewswire/ -- The "Respiratory Infection Diagnostic Markets by Technology, Plex, Place, Product and by Region With Executive and Consultant Guides 2024-2028"...
February 14, 2024
Co-Diagnostics, Inc. (NASDAQ:CODX – Get Free Report) was the target of a large drop in short interest in January. As of January 31st, there was short interest totalling 359,600 shares, a drop of 36.9% from the January 15th total of 570,000 shares. Based on an average daily volume of 109,500 shares, the short-interest ratio is […]
February 1, 2024
Co-Diagnostics, Inc. (NASDAQ:CODX – Get Free Report) saw a large drop in short interest during the month of January. As of January 15th, there was short interest totalling 570,000 shares, a drop of 9.8% from the December 31st total of 632,000 shares. Based on an average daily volume of 109,200 shares, the short-interest ratio is […]
February 1, 2024
/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the...
November 17, 2023
Co-Diagnostics (NASDAQ:CODX – Free Report) had its price target upped by HC Wainwright from $2.00 to $3.00 in a report released on Monday, Benzinga reports. The firm currently has a neutral rating on the stock. HC Wainwright also issued estimates for Co-Diagnostics’ Q4 2023 earnings at ($0.20) EPS, FY2023 earnings at ($0.90) EPS, Q1 2024 […]
October 31, 2023
/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the...